After more than 20 years’ experience in medical devices and in vitro diagnostic medical devices fields, I joined nexialist team in November 2022. With an academic background in biomaterials, I had the opportunity to work in different environments : Research...
Publications : Matières premières
MDCG 2023-3 Questions and Answers on vigilance terms and concepts as outlined in the Regulation (EU) 2017/745 on medical devices – February 2023
Theme Vigilance Target Audience Competent authorities, economic operators, and other interested parties Products concerned MD Regulatory reference MDR (EU) 2017/745 Documents mentioned MEDDEV 2.12/1 rev.8Regulation (EU) No 1025/2012EN ISO 15223-1:2021Manufacturer...
MDCG 2023-2 List of standard fees – January 2023
Theme List of standard fees Target Audience Notified bodies Products concerned MD, IVD Regulatory reference MDR (EU) 2017/745IVDR (EU) 2017/746 Documents mentioned MDCG 2019-6Recommendation 2003/361/EC Regulations (EU) 2017/745 and 2017/746 require Notified Bodies to...
MDCG 2023-1 Guidance on the health institution exemption under article 5(5) of Regulation (EU) 2017/745 and Regulation (EU) 2017/746 – January 2023
Theme In house devices Target Audience Health institutions, healthcare professionals Products concerned MD, IVD Regulatory reference MDR (EU) 2017/745IVDR (EU) 2017/746 Documents mentioned MDCG 2020-16MDCG 2021-24 This MDCG document addresses so-called "in house"...
MDCG 2022-21 Guidance on periodic safety update report (PSUR) according to regulation (EU) 2017/745 (MDR) – December 2022
Theme PSUR – Article 86 MDR Target Audience Manufacturers of class IIa, IIb, and III medical devices Products concerned MD Regulatory reference MDR (EU) 2017/745 Documents mentioned MDCG 2022-14MDCG 2021-25MDCG 2021-3MDCG 2021-1 rev.1IMDRF Adverse Event Terminology...
Martina Cotena
Expert biologist in the field of health. Holder of a Marie-Curie H2020 research doctorate in Health and Development Biology. This interdisciplinary project focused on identifying the effects of nanomaterials and organic pollutants on the reproductive toxicity of...
Government of the Netherlands: Legal analysis – European legislative proposal draft AI act and MDR/IVDR
Government of the Netherlands: Legal analysis – European legislative proposal draft AI act and MDR/IVDRGovernment of the Netherlands: Legal analysis – European legislative proposal draft AI act and MDR/IVDRThis legal analysis carried out by Hooghiemstra & Partners...
WHO Ethics and Governance of AI Systems
WHO Ethics and Governance of AI SystemsWHO Ethics and Governance of AI SystemsThe World Health Organization released a general report in 2021 on the use of artificial intelligence in health and the challenges and risks that these technologies can produce. In this...
MedTech Europe response to the open public consultation on the Proposal for an Artificial Intelligence Act (COM/2021/206)
MedTech Europe response to the open public consultation on the Proposal for an Artificial Intelligence Act (COM/2021/206)MedTech Europe response to the open public consultation on the Proposal for an Artificial Intelligence Act (COM/2021/206)MedTech Europe is a...
Joint statement in support of the New Legislative Framework and the AI Act
Joint statement in support of the New Legislative Framework and the AI ActJoint statement in support of the New Legislative Framework and the AI ActThe joint statement in favor of the new legislative framework and the AI law is a joint statement signed by a group of...